Arcturus Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Arcturus Therapeutics's estimated annual revenue is currently $31M per year.
- Arcturus Therapeutics received $3.0M in venture funding in May 2017.
- Arcturus Therapeutics's estimated revenue per employee is $131,915
- Arcturus Therapeutics's total funding is $302.4M.
Employee Data
- Arcturus Therapeutics has 235 Employees.
- Arcturus Therapeutics grew their employee count by -6% last year.
Arcturus Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Executive Assistant to President & CEO, CSO, CFO & VP, IR/PR/M | Reveal Email/Phone |
2 | CTO | Reveal Email/Phone |
3 | VP, Head Investor Relations/Public Relations/Marketing at Arcturus Therapeutics | Reveal Email/Phone |
4 | VP, Strategic Sourcing and Procurement | Reveal Email/Phone |
5 | VP, Clinical Operations | Reveal Email/Phone |
6 | VP Pulmonary and Rare Diseases | Reveal Email/Phone |
7 | VP, Global Business Development, Vaccines | Reveal Email/Phone |
8 | VP Clinical Development | Reveal Email/Phone |
9 | VP Head Technology Innovation | Reveal Email/Phone |
10 | SVP Translational Biology | Reveal Email/Phone |
Arcturus Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $11830M | 8030 | 26% | $2.7B | $83B |
#2 | $69340M | 107310 | 4% | N/A | $308.4B |
What Is Arcturus Therapeutics?
Arcturus Therapeutics is a preclinical drug delivery and nucleic acid medicines company. We are focused on developing novel technologies to build the next generation of safe, effective RNA and DNA medicines. We have proprietary technologies, validating partnerships, and an experienced team with deep expertise in delivery and nucleic acid-based therapeutics. Arcturus Therapeutics is presently recruiting outstanding candidates with experience in the field of RNA technologies and nanoparticle sciences. Only exceptional applicants need apply. Compensation and equity position is commensurate. Please email your resume to Careers@ArcturusRx.com, or visit https://arcturusrx.com/careers/
keywords:Biotechnology,Healthcare,Pharmaceuticals
$302.4M
Total Funding
235
Number of Employees
$31M
Revenue (est)
-6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Arcturus Therapeutics News
Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4). April 22, 2022 08:00 PM Eastern Daylight Time. SAN DIEGO--(BUSINESS...
Zacks: Analysts Expect Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Will Announce Earnings of -$1.29 Per Share. Posted by admin on Apr 23rd...
Arcturus Therapeutics Holdings Inc. has reported topline data from an ongoing Phase 1/2/3 trial evaluating ARCT-154, its self-amplifying...
SAN DIEGO, Aug. 26, 2019 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Holdings Inc. (“Arcturus Therapeutics”) (ARCT), a leading ...
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $47.6M | 237 | 17% | N/A |
#2 | $41.7M | 237 | 16% | N/A |
#3 | $84.6M | 238 | 20% | N/A |
#4 | $15M | 239 | 49% | N/A |
#5 | $52.8M | 239 | 21% | N/A |
Arcturus Therapeutics Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2013-06-04 | $1.3M | Undisclosed | Article | |
| 2013-10-02 | $2.1M | Undisclosed | Article | |
| 2013-10-22 | $5.0M | A | Article | |
| 2017-05-31 | $3.0M | Undisclosed | Cystic Fibrosis Foundation Therapeutics | Article |